Ethics of medication-free research in schizophrenia

Schizophrenia Bulletin

Volumn 32, Issue 2, 2006, Pages 307-309

  Chen, Donna T ^a,b,c   Moreno, Jonathan D ^c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; CLINICAL TRIAL; DISEASE COURSE; HUMAN; MEDICAL ETHICS; MEDICAL RESEARCH; META ANALYSIS; NOTE; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SYSTEMATIC REVIEW;

BIOMEDICAL RESEARCH; ETHICS, MEDICAL; HARM REDUCTION; HUMANS; SCHIZOPHRENIA; WITHHOLDING TREATMENT;

EID: 33645212808     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbj049     Document Type: Note

References (7)

1. Bola JR. Medication-free research in early episode schizophrenia: Evidence of long-term harm? Schizophr Bull. 2006;32(2).
2. Emanuel EJ, Miller FG. The ethics of placebo-controlled trials - a middle ground. N Engl J Med. 2001 Sep 20;345(12):915-919.
3. Carpenter WT Jr, Schooler NR, Kane JM. The rationale and ethics of medication-free research in schizophrenia. Arch Gen Psychiatry. 1997 May;54(5):401-407.
4. Kemmler G, Hummer M, Widschwendter C, Fleischhacker WW. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis. Arch Gen Psychiatry. 2005 Dec;62:1305-1312.
5. Woods SW, Gueorguieva RV, Baker CB, Makuch RW. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia. Arch Gen Psychiatry. 2005 Sep;62:961-970.
6. Brody BA, McCullough LB, Sharp RR. Consensus and controversy in clinical research ethics. JAMA. 2005 Sep 21;294:1411-1414.
7. Dunn LB, Candilis PJ, Roberts LW. Reviews: emerging empirical evidence on the ethics of schizophrenia research. Schizophr Bull. 2006;32:47-68.